Quick answer
Enclomiphene stimulates your own testosterone production — preserves fertility and doesn't suppress your natural hormonal axis. TRT replaces testosterone externally — faster, more predictable results, but suppresses natural production and sperm count. Marrow offers both protocols with physician oversight.
Testosterone Optimization
Enclomiphene vs TRT: The Hormone Optimization Decision Most Men Get Wrong
Two paths to optimizing testosterone. One preserves your natural axis and fertility. The other delivers faster, more reliable results. Here's how to think about the choice.
How enclomiphene works
Enclomiphene is the active trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM). It works at the level of your brain's control center — the hypothalamus and pituitary gland — by blocking estrogen receptors that normally signal "we have enough testosterone, stop producing more."
With those receptors blocked, your pituitary releases more luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH tells your testes to produce more testosterone. FSH maintains sperm production. The result: higher testosterone levels and preserved fertility — your body is doing the work, just with a stronger signal.
Most men on enclomiphene see testosterone increases of 200-400 ng/dL within 4-8 weeks, depending on their starting point and response. Because your testes are still functioning (and being actively stimulated), testicular atrophy — a common side effect of TRT — doesn't occur.
How TRT works
Testosterone replacement therapy delivers exogenous (external) testosterone directly into your body — typically via weekly intramuscular or subcutaneous injections, though topical gels and pellets exist. Your blood testosterone levels rise quickly and predictably.
The tradeoff: your hypothalamic-pituitary-gonadal (HPG) axis detects the external testosterone and shuts down its own production. LH and FSH plummet. Your testes stop producing testosterone and sperm. This is why TRT is effectively male contraception in most men — and why it causes testicular atrophy over time.
TRT is the gold standard for confirmed hypogonadism (total testosterone consistently below 300 ng/dL with symptoms). It's reliable, well-studied, and delivers results that patients can feel within 2-4 weeks — improved energy, mood, libido, and body composition changes within 3-6 months.
Who should choose enclomiphene
Enclomiphene is typically the better first-line choice for men who fit one or more of these profiles:
- Men under 40 who want to optimize testosterone without committing to lifelong therapy. Enclomiphene can be discontinued without the prolonged HPG axis recovery that TRT requires.
- Men who want to preserve fertility. If you're planning to have children — now or in the future — enclomiphene maintains or even improves sperm production, while TRT effectively shuts it down.
- Suboptimal but not critically low testosterone. If your total T is 350-550 ng/dL and you have symptoms (fatigue, brain fog, low libido), enclomiphene can push you into the optimal range without replacing your entire endocrine system.
- Men with elevated BMI. Excess body fat increases aromatase activity, converting testosterone to estrogen. Enclomiphene's estrogen-blocking mechanism can be particularly effective in this population.
Who should choose TRT
TRT is the appropriate choice when:
- Confirmed hypogonadism — total testosterone consistently below 300 ng/dL on morning labs, with clinical symptoms. At this level, the testes often can't respond adequately to increased LH stimulation from enclomiphene.
- No fertility concerns. You've completed your family or have no plans for biological children.
- Prior enclomiphene trial without adequate response. Some men are non-responders to SERMs — their testes simply don't produce more testosterone despite increased LH.
- Desire for faster, more predictable results. TRT delivers a known dose of testosterone. There's less variability in response compared to enclomiphene, which depends on your testes' ability to respond.
Enclomiphene vs TRT: head-to-head
| Factor | Enclomiphene | TRT |
|---|---|---|
| Mechanism | Stimulates natural production | Replaces testosterone externally |
| Fertility impact | Preserves or improves | Suppresses (often to zero) |
| Time to results | 4-8 weeks | 2-4 weeks |
| Testicular atrophy | No | Yes (over time) |
| HPG axis suppression | No | Yes |
| Result predictability | Variable (depends on response) | Highly predictable |
| Discontinuation | Can stop without prolonged recovery | Requires PCT or gradual taper |
| Monitoring | Labs every 8-12 weeks initially | Labs every 8-12 weeks initially |
| Cost at Marrow | From $149/mo | From $179/mo |
Marrow's protocol for both
Marrow doesn't push one over the other. During your intake, a licensed physician reviews your labs, symptoms, age, fertility goals, and preferences to recommend the right protocol. Some patients start on enclomiphene and transition to TRT if response is insufficient. Others go straight to TRT based on their clinical picture.
Physician review
Licensed MD reviews your intake, labs, and goals within 24 hours
Lab work
Total & free testosterone, LH, FSH, estradiol, CBC, metabolic panel
Compounded medication
From FDA-registered 503B pharmacies — enclomiphene or testosterone cypionate
Ongoing monitoring
Follow-up labs at 8-12 weeks, dose adjustments based on response
Learn more about our testosterone protocols or explore TRT in detail.
Frequently asked questions
What is enclomiphene?
Enclomiphene is the active trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM). It works by blocking estrogen receptors in the hypothalamus and pituitary, which stimulates your body to produce more luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — resulting in increased natural testosterone production while preserving fertility.
Is enclomiphene FDA approved?
Enclomiphene is not currently FDA-approved as a standalone medication. However, it is legally available through compounding pharmacies when prescribed by a licensed physician. Clomiphene citrate (which contains enclomiphene) has been used off-label for male hypogonadism for decades with a well-established safety profile.
Does TRT cause infertility?
Yes, in most cases. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, which dramatically reduces or eliminates sperm production. For men who want to preserve fertility, this is the primary reason to consider enclomiphene instead. Fertility typically returns after discontinuing TRT, but recovery can take 6-12 months or longer.
How do the costs compare?
At Marrow, enclomiphene protocols start at $149/month and TRT protocols start at $179/month. Both include physician oversight, medication from FDA-registered pharmacies, and ongoing monitoring. Brand-name testosterone from retail pharmacies typically runs $200-400/month before insurance.
How do I decide between enclomiphene and TRT?
The decision depends on your age, fertility goals, severity of testosterone deficiency, and how quickly you need results. If you're under 40, want to preserve fertility, or have suboptimal (not critically low) testosterone, enclomiphene is usually the first-line approach. If you have confirmed hypogonadism, no fertility concerns, and want the most reliable results, TRT may be more appropriate. A Marrow physician can help you decide during your intake.
Find the right testosterone protocol
5-minute intake. Physician reviews your labs and goals within 24 hours. Medication ships in 3-5 days.
Start your intake →Enclomiphene from $149/mo · TRT from $179/mo · Physician approval required